Patents by Inventor Simone Hornemann

Simone Hornemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccinia virus MVA-E3L-knockout-mutants and use thereof
    Patent number: 7049145
    Abstract: The present invention relates to mutant MVA vaccinia viruses, which are used for the generation of recombinant MVA viruses, as well as host cells, which have been infected with these mutant MVA viruses. The present invention further relates to DNA-vector constructs, and a method for the generation of recombinant MVA by using the mutant MVA viruses and the DNA-vector constructs. The mutant MVA vaccinia viruses of the present invention are characterized in that the MVA ORF 050L gene or a functional part thereof has been inactivated in the viral genome.
    Type: Grant
    Filed: September 11, 2002
    Date of Patent: May 23, 2006
    Assignee: GSF-Forschungszentrum fur Umwelt und Gesundheit, GmbH
    Inventors: Volker Erfle, Simone Hornemann, Gerd Sutter
  • Vaccinia virus mva-e3L-knockout-mutants and use thereof
    Publication number: 20050028226
    Abstract: The present invention relates to mutant MVA vaccinia viruses, which are used for the generation of recombinant MVA viruses, as well as host cells, which have been infected with these mutant MVA viruses. The present invention further relates to DNA-vector constructs, and a method for the generation of recombinant MVA by using the mutant MVA viruses and the DNA-vector constructs. The mutant MVA vaccinia viruses of the present invention are characterized in that the MVA ORF 050L gene or a functional part thereof has been inactivated in the viral genome.
    Type: Application
    Filed: September 11, 2002
    Publication date: February 3, 2005
    Inventors: Volker Erfle, Simone Hornemann, Gerd Sutter